WO2023027638A3 - Polyfluorophore nanoreporters for fluorogenic imaging and early diagnosis - Google Patents
Polyfluorophore nanoreporters for fluorogenic imaging and early diagnosis Download PDFInfo
- Publication number
- WO2023027638A3 WO2023027638A3 PCT/SG2022/050602 SG2022050602W WO2023027638A3 WO 2023027638 A3 WO2023027638 A3 WO 2023027638A3 SG 2022050602 W SG2022050602 W SG 2022050602W WO 2023027638 A3 WO2023027638 A3 WO 2023027638A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- subject
- polyfluorophore
- nanoreporters
- fluorogenic
- imaging
- Prior art date
Links
- 238000013399 early diagnosis Methods 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 210000000056 organ Anatomy 0.000 abstract 3
- 230000001575 pathological effect Effects 0.000 abstract 3
- 210000002700 urine Anatomy 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Disclosed herein is a polymeric nanoreporter compound according to formula I, or a pharmaceutically acceptable salt or solvate thereof, and its uses. Also disclosed herein is a method of detecting a pathological condition in a subject, the method comprising the steps of (a) administering a polymeric nanoreporter compound according to formula I, or a pharmaceutically acceptable salt or solvate thereof, that targets the selected pathological condition to a subject; and (b) detecting any fluorescence in one or both of urine from the subject and an organ or a tissue in the subject that is targeted by the polymeric nanoreporter compound according to formula I, wherein the presence of the pathological condition in the subject is indicated by fluorescence in the urine, the tissue or organ, or both the urine and the tissue or organ.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202280057428.2A CN117858731A (en) | 2021-08-23 | 2022-08-23 | Multi-fluorophore nanoreporters for fluorescence imaging and early diagnosis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10202109190P | 2021-08-23 | ||
SG10202109190P | 2021-08-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2023027638A2 WO2023027638A2 (en) | 2023-03-02 |
WO2023027638A3 true WO2023027638A3 (en) | 2023-04-13 |
WO2023027638A9 WO2023027638A9 (en) | 2023-05-11 |
Family
ID=85323513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SG2022/050602 WO2023027638A2 (en) | 2021-08-23 | 2022-08-23 | Polyfluorophore nanoreporters for fluorogenic imaging and early diagnosis |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN117858731A (en) |
WO (1) | WO2023027638A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110213121A1 (en) * | 2008-08-29 | 2011-09-01 | Ick-Chan Kwon | Nanoparticle sensor for measuring protease activity and method for manufacturing the same |
WO2018064383A1 (en) * | 2016-09-28 | 2018-04-05 | Georgia Tech Research Corporation | Methods and compositions for noninvasive detection of organ transplant rejection |
WO2020081635A2 (en) * | 2018-10-16 | 2020-04-23 | Massachusetts Institute Of Technology | Renal clearable nanocatalysts for disease monitoring |
-
2022
- 2022-08-23 WO PCT/SG2022/050602 patent/WO2023027638A2/en active Application Filing
- 2022-08-23 CN CN202280057428.2A patent/CN117858731A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110213121A1 (en) * | 2008-08-29 | 2011-09-01 | Ick-Chan Kwon | Nanoparticle sensor for measuring protease activity and method for manufacturing the same |
WO2018064383A1 (en) * | 2016-09-28 | 2018-04-05 | Georgia Tech Research Corporation | Methods and compositions for noninvasive detection of organ transplant rejection |
WO2020081635A2 (en) * | 2018-10-16 | 2020-04-23 | Massachusetts Institute Of Technology | Renal clearable nanocatalysts for disease monitoring |
Non-Patent Citations (2)
Title |
---|
HUANG, J. ET AL.: "Activatable Molecular Probes for Second Near-Infrared Fluorescence, Chemiluminescence, and Photoacoustic Imaging", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 59, no. 29, 13 July 2020 (2020-07-13), pages 11717 - 11731, XP072101418, [retrieved on 20230301], DOI: 10.1002/ANIE.202001783 * |
HUANG, J. ET AL.: "Renal clearable polyfluorophore nanosensors for early diagnosis of cancer and allograft rejection", NATURE MATERIALS, vol. 21, no. 5, 14 April 2022 (2022-04-14), pages 598 - 607, XP037815790, [retrieved on 20230301], DOI: 10.1038/S41563-022-01224-2 * |
Also Published As
Publication number | Publication date |
---|---|
CN117858731A (en) | 2024-04-09 |
WO2023027638A2 (en) | 2023-03-02 |
WO2023027638A9 (en) | 2023-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stirrett et al. | Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis | |
US20210154187A1 (en) | Compositions and methods for treating pulmonary vascular disease | |
WO2009036082A3 (en) | Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use | |
JP2019189639A (en) | Compositions and methods for treating diabetes and liver diseases | |
Drago et al. | Psoriasis and small intestine bacterial overgrowth | |
PH12021550512A1 (en) | Imidazopyridinone compound | |
WO2023027638A3 (en) | Polyfluorophore nanoreporters for fluorogenic imaging and early diagnosis | |
US10544167B2 (en) | Compounds as stimuli-responsive probes, methods and applications thereof | |
US20210353624A1 (en) | Method of treating cancer with telotrisat or a prodrug thereof | |
WO2023018377A3 (en) | Ultrabright chemiluminescent probes for detection and imaging | |
Tawfik Amin et al. | Activation of nuclear factor kappa B and induction of migration inhibitory factor in tumors by surgical stress of laparotomy versus carbon dioxide pneumoperitoneum: an animal experiment | |
Sateesh et al. | Comparative analysis between single incision and conventional laparoscopic appendectomy for acute appendicitis | |
Kiyono et al. | Non-invasive diagnosis of portal hypertensive gastropathy: quantitative analysis of microbubble-induced stomach wall enhancement | |
NZ590993A (en) | Dual specificity phosphatase 1 protein (DUSP1) for diagnosis and prognosis of skin cancer | |
Hall et al. | Panton–Valentine leukocidin Staphylococcus aureus osteomyelitis of the adult tibia–a case report | |
Lee et al. | A rare cause of ischemic gut: A case report | |
Funada et al. | Laparoscopic partial cystectomy with excision of mesh migration into the bladder following repair of inguinal hernia | |
RU2576793C1 (en) | Method for prediction of multiple organ failure accompanying first stage of organ dysfunction in patients with diffuse peritonitis | |
RU2280408C1 (en) | Method for detecting necrosis in case of acute destructive pancreatitis | |
RU2305496C1 (en) | Early diagnosis method for determining pulmonary mycosis cases using multi-spiral computer tomography and high resolution computer tomography | |
RU2409317C1 (en) | Method to forecast liver impairment development in post-operational period in patients after hemihepatectomy | |
Di Palma et al. | Gastrointestinal mucormycosis after abdominal aortic aneurysm repair and prolonged hospitalization: A case report and review of the literature | |
Oleka et al. | Paracoccus yeei in persistent pediatric groin lesion | |
Yildirim et al. | Bilateral symptomatic petrous apex effusion | |
WO2023141522A3 (en) | Multicyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 202280057428.2 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |